Validation of the Modified Frailty Phenotype Measure in Older Mexican Americans.


Journal

Journal of the American Geriatrics Society
ISSN: 1532-5415
Titre abrégé: J Am Geriatr Soc
Pays: United States
ID NLM: 7503062

Informations de publication

Date de publication:
11 2019
Historique:
received: 15 05 2019
revised: 28 06 2019
accepted: 10 07 2019
pubmed: 16 8 2019
medline: 22 5 2020
entrez: 16 8 2019
Statut: ppublish

Résumé

Develop and validate a modified frailty phenotype measure for older Mexican Americans participating in the Hispanic Established Populations for the Epidemiological Study of the Elderly (H-EPESE) and related studies. Expert-based panel evaluation of content validity, cross-sectional analysis of construct validity, and longitudinal analysis of criterion validity for a modified version of the frailty phenotype measure. Five southwestern states. A total of 1833 community-dwelling Mexican Americans aged 67 years or older. Frailty was assessed using the frailty phenotype measure (weight loss, weakness, exhaustion, slowness, and low physical activity) and a modified frailty phenotype measure (replacing "low physical activity" with "limitations in walking half a mile"). Each individual was classified as non-frail, pre-frail, or frail based on both frailty measures (original vs modified). Expert panel consensus was used to examine content validity. Spearman correlation, κ, weighted κ, and bootstrapping κ examined construct validity (n = 1833). Generalized linear mixed models, odds ratios, Cox proportional regression models, hazard ratios, and C statistics were used to analyze criterion validity (n = 1446) across four outcomes: hospitalization, physician visits, disability, and mortality from wave 3 (1998-99) through wave 8 (2012-13). The original and modified frailty phenotype measures had a strong correlation (r = .89; P < .000) and agreement (κ = .84; 95% confidence interval [CI] = .81-.86; weighted κ = .86; 95% CI = .84-.88; bootstrap κ = .84; 95% CI = .81-.86; bootstrap-weighted κ = .86; 95% CI = .84-.88 with 1000 bootstrapping samples). Four outcome models showed similar risk predictions for both frailty measures, with the exception of physician visits for frail participants. "Limitations in walking half a mile" can be used as a substitute criterion for "low physical activity" in assessing frailty. The modified frailty phenotype measure was comparable with the original frailty phenotype measure in H-EPESE participants over time. Our results indicate the modified frailty phenotype is a useful longitudinally frailty measure for community-dwelling older Mexican Americans. J Am Geriatr Soc 67:2393-2397, 2019.

Identifiants

pubmed: 31414494
doi: 10.1111/jgs.16104
pmc: PMC6861608
mid: NIHMS1045311
doi:

Types de publication

Journal Article Multicenter Study Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

2393-2397

Subventions

Organisme : NIA NIH HHS
ID : P30 AG059301
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG010939
Pays : United States
Organisme : NIMHD NIH HHS
ID : R01 MD010355
Pays : United States
Organisme : NIA NIH HHS
ID : R01-AG10939
Pays : United States

Informations de copyright

© 2019 The American Geriatrics Society.

Références

Lancet. 2013 Mar 2;381(9868):752-62
pubmed: 23395245
J Gerontol A Biol Sci Med Sci. 2007 Jul;62(7):744-51
pubmed: 17634322
Biochem Med (Zagreb). 2012;22(3):276-82
pubmed: 23092060
J Gerontol A Biol Sci Med Sci. 2000 Dec;55(12):M706-8
pubmed: 11129391
Clin Geriatr Med. 2011 Feb;27(1):17-26
pubmed: 21093719
Stat Med. 2004 Jul 15;23(13):2109-23
pubmed: 15211606
Ann Epidemiol. 2018 Jun;28(6):362-367.e3
pubmed: 29703521
JAMA. 1963 Sep 21;185:914-9
pubmed: 14044222
Circulation. 2007 Feb 20;115(7):928-35
pubmed: 17309939
J Gerontol A Biol Sci Med Sci. 2015 Nov;70(11):1427-34
pubmed: 26297656
BMC Geriatr. 2010 Aug 24;10:57
pubmed: 20731877
J Clin Epidemiol. 1993 Feb;46(2):153-62
pubmed: 8437031
Intensive Care Med. 2017 Aug;43(8):1105-1122
pubmed: 28676896
Am J Public Health. 2009 Apr;99(4):673-9
pubmed: 19197079
J Nutr Health Aging. 2012 Feb;16(2):142-7
pubmed: 22323349
Rev Bras Enferm. 2016 Jul-Aug;69(4):691-6
pubmed: 27508474
J Gerontol A Biol Sci Med Sci. 2007 Jul;62(7):738-43
pubmed: 17634321
J Gerontol A Biol Sci Med Sci. 2007 Jul;62(7):722-7
pubmed: 17634318
Ageing Res Rev. 2015 May;21:78-94
pubmed: 25846451
J Gerontol A Biol Sci Med Sci. 2002 May;57(5):M283-8
pubmed: 11983721
J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M134-5
pubmed: 11253153
J Gerontol A Biol Sci Med Sci. 2006 Mar;61(3):262-6
pubmed: 16567375
J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56
pubmed: 11253156
J Am Geriatr Soc. 2007 Aug;55(8):1216-23
pubmed: 17661960
J Am Geriatr Soc. 2005 Jun;53(6):927-34
pubmed: 15935013
J Nerv Ment Dis. 1987 Dec;175(12):731-7
pubmed: 3500273
Age Ageing. 2005 Sep;34(5):432-4
pubmed: 16107450

Auteurs

Chih-Ying Li (CY)

Department of Occupational Therapy, School of Health Professions, University of Texas Medical Branch, Galveston, Texas.

Soham Al Snih (S)

Division of Rehabilitation, School of Health Professions, University of Texas Medical Branch, Galveston, Texas.
Division of Geriatrics, Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas.
Sealy Center on Aging, University of Texas Medical Branch, Galveston, Texas.

Nai-Wei Chen (NW)

Department of Preventive Medicine and Community Health, Office of Biostatistics, University of Texas Medical Branch, Galveston, Texas.

Kyriakos S Markides (KS)

Division of Sociomedical Sciences, Department of Preventive Medicine and Community Health, University of Texas Medical Branch, Galveston, Texas.

Jaspreet Sodhi (J)

Division of Rehabilitation, School of Health Professions, University of Texas Medical Branch, Galveston, Texas.

Kenneth J Ottenbacher (KJ)

Division of Rehabilitation, School of Health Professions, University of Texas Medical Branch, Galveston, Texas.
Sealy Center on Aging, University of Texas Medical Branch, Galveston, Texas.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH